MESQUITE, Texas, May 30, 2024 — MPM Medical, a developer and distributor of advanced wound care products, has presented new data on two flagship products—TripleHelix™ Collagen, a 100% Type I Bovine Collagen, and RegeneCare HA™, a 2% Lidocaine Hydrogel with an aloe vera base containing collagen and hyaluronic acid.
Studies have highlighted the TripleHelix™ collagen powder’s ability to reduce erythema and edema, as well as provide a greater reduction in wound size when compared to the standard wound dressing. RegeneCare HA™ was noted as not significantly increasing the risk for lidocaine toxicity. The study also suggests that RegeneCare HA™ is a preferable alternative to topical lidocaine to control pain and promote wound healing.
The data and new branding were showcased at the 2024 Symposium on Advanced Wound Care (SAWC) Spring Conference in Orlando, Florida. Posters are now available online:
Caitlin Crews-Stowe, Ph.D., MPH, CPH, CIC, CPHQ, VA-BC, presented the data and noted, “Chronic wounds have been called our ’silent epidemic’. Finding a safe and effective alternative to traditional dressings to treat these wounds, as well as stagnant and hard-to-heal wounds, is crucial. We are thrilled to share the results on TripleHelix.”
Nathan Lavalle, CWCMS, MPM Medical National Sales Manager adds, “The wound care professionals that we serve care tremendously about their patients. They are in dire need of safe and effective solutions for patients with painful wounds. We are proud to offer them a proven and unique product with RegeneCare HA”.
In addition to showcasing new data, MPM Medical was featured as a new product spotlight and unveiled its new corporate branding and product packaging. The new packaging, as well as new ExcelSAP™ silicone super absorbent dressing sizes, will be available later this year. View the entire advanced wound care product line on MPM Medical’s new website, mpmmed.com.